FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Do More to Capture Nonprescription Drug Use Info: Meeting

[ Price : $8.95]

Participants in a 4/23 FDA meeting on increasing access to nonprescription drugs see a need to improve the electronic health recor...

Osfamide Shortage Seen

[ Price : $8.95]

An oncology physician association says its members are reporting a shortage of the chemotherapy agent ifosfamide for which no dire...

FDA Issues Alert on Abiomed Impella Controllers

[ Price : $8.95]

CDRH issues an early alert to notify the public about an Abiomed action recommending that all Automated Impella Controllers be rem...

Petition Seeks Carbetocin OK for Postpartum Hemorrhage

[ Price : $8.95]

Two physicians affiliated with Stanford Universitys medical school urge FDA to approve carbetocin for preventing postpartum hemorr...

Jemperli sBLA for Rectal Cancer Accepted for Priority Review

[ Price : $8.95]

FDA accepts for priority review a GSK supplemental BLA for Jemperli (dostarlimab) for certain patients with previously untreated S...

Comments on Expedited IND Pilot

[ Price : $8.95]

Three stakeholders provide their responses to an FDA Request for Information on the Operation TrialBlazer Expedited IND Pilot Proj...

Device, Drug Recalls Down, Units Up

[ Price : $8.95]

The Sedgwick Recall Index shows that in the first half of 2026, medical device and drug recalls fell, but the number of recalled u...

Wearable Device Monitors Ketone Levels and Blood Sugar

[ Price : $8.95]

FDA grants Abbott Diabetes Care a de novo authorization for the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System ...

Group Backs Circulating Tumor DNA as Early Endpoint

[ Price : $8.95]

Friends of Cancer Research publishes two scientific articles it says demonstrate the value of circulating tumor DNA as an early en...

R3 Selling Unapproved Drugs, Biologics, FDA Says

[ Price : $8.95]

FDA warns Scottsdale, AZ-based R3 Medical Companies that its Bello Bio and Regen Suppliers units are selling unapproved drugs that...